Regeneron Pharmaceuticals (REGN) Tax Rate (2011 - 2026)

Regeneron Pharmaceuticals' Tax Rate history runs 16 years deep, the most recent figure standing at 12.51% for Q1 2026.

• On a quarterly basis, Tax Rate rose 187.0% year-over-year to 12.51% in Q1 2026; TTM through Mar 2026 was 14.22%, a 449.0% increase from a year earlier, with the FY2025 full-year figure at 13.88%, up 619.0% from the prior year.
• Tax Rate slipped to 12.51% in Q1 2026 per REGN's latest filing, from 19.08% in the prior quarter.
• Across five years, Tax Rate topped out at 19.08% in Q4 2025 and bottomed at 3.04% in Q1 2024.
• The 5-year median for Tax Rate is 10.21% (2024), against an average of 9.23%.
• Across the five-year window, Tax Rate plunged 1068 bps in 2023 and jumped 1486 bps in 2025, its largest moves.
• Year by year, Tax Rate stood at 9.63% in 2022, then sank by 111 bps to 1.05% in 2023, then jumped by 503 bps to 4.22% in 2024, then surged by 352 bps to 19.08% in 2025, then sank by 34 bps to 12.51% in 2026.
• Per Business Quant, the three latest REGN Tax Rate figures stand at 12.51% (Q1 2026), 19.08% (Q4 2025), and 17.2% (Q3 2025).